a5e2255f971bda3693f31978843844bb  324412.pdf
1f5cb3df1eea470287d2ff27ffefe53eaee62e23  324412.pdf
9a8d17ccc216774e4343b28fab628c907e055899234066b47dca9464f4181f2f  324412.pdf

Keywords:        renal cell carcinoma, lenvatinib, pembrolizumab, sunitinib, bone metastases, liver metastases, lung metastases, sarcomatoid histology
Custom Metadata: no
Metadata Stream: yes
Tagged:          no
UserProperties:  no
Suspects:        no
Form:            none
JavaScript:      no
Pages:           2
Encrypted:       no
Page size:       595.389 x 841.663 pts (A4)
Page rot:        0
File size:       1474763 bytes
Optimized:       no
PDF version:     1.4


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
IOICLC+AdvTTd3a5f740                 Type 1C           WinAnsi          yes yes no      73  0
IOICMD+AdvTTd3a5f740+01              Type 1C           MacRoman         yes yes no      74  0
IOICME+AdvPSA18C                     Type 1C           WinAnsi          yes yes no      75  0
IOICMF+AdvTT9b12cd41                 Type 1C           WinAnsi          yes yes no      76  0
IOICMG+AdvTT9b12cd41+20              Type 1C           WinAnsi          yes yes no      82  0
IOICMH+AdvPSA323                     Type 1C           WinAnsi          yes yes no      83  0
IOICMI+AdvTT9b12cd41+01              Type 1C           MacRoman         yes yes no      84  0
IOICNJ+AdvTT9b12cd41+fb              Type 1C           Custom           yes yes yes     86  0
IOICNK+AdvTT2c8ce45a                 Type 1C           WinAnsi          yes yes no      87  0
IOICNL+AdvTT58d178b9+03              Type 1C           Custom           yes yes yes     88  0
IOICNM+AdvTTd168d80a.I               Type 1C           WinAnsi          yes yes no      89  0
IOIGGH+AdvOT1ef757c0                 Type 1C           WinAnsi          yes yes no      22  0
IOIGGI+AdvOT1ef757c0+fb              Type 1C           Custom           yes yes yes     24  0
IOIGGJ+AdvOT1ef757c0+20              Type 1C           WinAnsi          yes yes no      25  0
IOIGGK+AdvOT7d6df7ab.I               Type 1C           WinAnsi          yes yes no      26  0
IOIGGL+AdvTTd3a5f740+20              Type 1C           WinAnsi          yes yes no      23  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2026-02-19 04:16:34 CET
 RepresentationInformation: 324412.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2026-02-18 08:35:07 CET
  Size: 1474763
  Format: PDF
  Version: 1.4
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  PDFMetadata: 
   Objects: 140
   FreeObjects: 3
   IncrementalUpdates: 2
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseOutlines
    Outlines: 
     Item: 
      Title: Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
      Destination: bmark_-86402627
      Children: 
       Item: 
        Title: Publisher’s note
        Destination: bmark_-1256977648
   Info: 
    Keywords: renal cell carcinoma, lenvatinib, pembrolizumab, sunitinib, bone metastases, liver metastases, lung metastases, sarcomatoid histology
   ID: 0xebce0c8ab74e2aaf2b995ee41858b8e1, 0xa41089544cf19141ba71225dc116262e
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 2919
      ImageHeight: 577
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 4203
      ImageHeight: 3700
      BitsPerSample: 8
      BitsPerSampleUnit: integer
   Fonts: 
    Type1: 
     Font: 
      BaseFont: IOICLC+AdvTTd3a5f740
      FontSubset: true
      FirstChar: 42
      LastChar: 252
      FontDescriptor: 
       FontName: IOICLC+AdvTTd3a5f740
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 916, 885
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOICMD+AdvTTd3a5f740+01
      FontSubset: true
      FirstChar: 245
      LastChar: 245
      FontDescriptor: 
       FontName: IOICMD+AdvTTd3a5f740+01
       Flags: Nonsymbolic
       FontBBox: -52, -208, 947, 885
       FontFile3: true
      Encoding: MacRomanEncoding
     Font: 
      BaseFont: IOICME+AdvPSA18C
      FontSubset: true
      FirstChar: 180
      LastChar: 180
      FontDescriptor: 
       FontName: IOICME+AdvPSA18C
       Flags: Nonsymbolic
       FontBBox: -156, -208, 1125, 802
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOICMF+AdvTT9b12cd41
      FontSubset: true
      FirstChar: 38
      LastChar: 252
      FontDescriptor: 
       FontName: IOICMF+AdvTT9b12cd41
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 906, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOICMG+AdvTT9b12cd41+20
      FontSubset: true
      FirstChar: 145
      LastChar: 146
      FontDescriptor: 
       FontName: IOICMG+AdvTT9b12cd41+20
       Flags: Nonsymbolic
       FontBBox: -114, -166, 1010, 864
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOICMH+AdvPSA323
      FontSubset: true
      FirstChar: 180
      LastChar: 180
      FontDescriptor: 
       FontName: IOICMH+AdvPSA323
       Flags: Nonsymbolic
       FontBBox: -156, -239, 1104, 770
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOICMI+AdvTT9b12cd41+01
      FontSubset: true
      FirstChar: 245
      LastChar: 245
      FontDescriptor: 
       FontName: IOICMI+AdvTT9b12cd41+01
       Flags: Nonsymbolic
       FontBBox: -52, -208, 958, 875
       FontFile3: true
      Encoding: MacRomanEncoding
     Font: 
      BaseFont: IOICNJ+AdvTT9b12cd41+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: IOICNJ+AdvTT9b12cd41+fb
       Flags: Symbolic
       FontBBox: 0, 0, 854, 697
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: IOIGGH+AdvOT1ef757c0
      FontSubset: true
      FirstChar: 40
      LastChar: 122
      FontDescriptor: 
       FontName: IOIGGH+AdvOT1ef757c0
       Flags: Serif, Nonsymbolic
       FontBBox: -20, -250, 947, 854
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOICNK+AdvTT2c8ce45a
      FontSubset: true
      FirstChar: 42
      LastChar: 122
      FontDescriptor: 
       FontName: IOICNK+AdvTT2c8ce45a
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 947, 895
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOIGGL+AdvTTd3a5f740+20
      FontSubset: true
      FirstChar: 146
      LastChar: 146
      FontDescriptor: 
       FontName: IOIGGL+AdvTTd3a5f740+20
       Flags: Nonsymbolic
       FontBBox: -114, -166, 1062, 864
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOICNL+AdvTT58d178b9+03
      FontSubset: true
      FirstChar: 0
      LastChar: 0
      FontDescriptor: 
       FontName: IOICNL+AdvTT58d178b9+03
       Flags: Symbolic
       FontBBox: -645, -354, 916, 895
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: IOIGGI+AdvOT1ef757c0+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: IOIGGI+AdvOT1ef757c0+fb
       Flags: Symbolic
       FontBBox: 0, -10, 781, 708
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: IOICNM+AdvTTd168d80a.I
      FontSubset: true
      FirstChar: 46
      LastChar: 116
      FontDescriptor: 
       FontName: IOICNM+AdvTTd168d80a.I
       Flags: Serif, Nonsymbolic
       FontBBox: -145, -208, 968, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOIGGJ+AdvOT1ef757c0+20
      FontSubset: true
      FirstChar: 147
      LastChar: 148
      FontDescriptor: 
       FontName: IOIGGJ+AdvOT1ef757c0+20
       Flags: Nonsymbolic
       FontBBox: -135, -187, 1010, 833
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IOIGGK+AdvOT7d6df7ab.I
      FontSubset: true
      FirstChar: 79
      LastChar: 118
      FontDescriptor: 
       FontName: IOIGGK+AdvOT7d6df7ab.I
       Flags: Nonsymbolic
       FontBBox: -135, -250, 1000, 854
       FontFile3: true
      Encoding: WinAnsiEncoding
   XMP: <x:xmpmeta xmlns:x='adobe:ns:meta/' x:xmptk='Image::ExifTool 12.52'>
<rdf:RDF xmlns:rdf='http://www.w3.org/1999/02/22-rdf-syntax-ns#'>

 <rdf:Description rdf:about=''
  xmlns:dc='http://purl.org/dc/elements/1.1/'>
  <dc:creator>
   <rdf:Seq>
    <rdf:li>Viktor Grünwald</rdf:li>
    <rdf:li>Thomas Powles</rdf:li>
    <rdf:li>Masatoshi Eto</rdf:li>
    <rdf:li>Evgeny Kopyltsov</rdf:li>
    <rdf:li>Sun Young Rha</rdf:li>
    <rdf:li>Camillo Porta</rdf:li>
    <rdf:li>Robert Motzer</rdf:li>
    <rdf:li>Thomas E. Hutson</rdf:li>
    <rdf:li>María José Méndez-Vidal</rdf:li>
    <rdf:li>Sung-Hoo Hong</rdf:li>
    <rdf:li>Eric Winquist</rdf:li>
    <rdf:li>Jeffrey C. Goh</rdf:li>
    <rdf:li>Pablo Maroto</rdf:li>
    <rdf:li>Tomas Buchler</rdf:li>
    <rdf:li>Toshio Takagi</rdf:li>
    <rdf:li>Joseph E. Burgents</rdf:li>
    <rdf:li>Rodolfo Perini</rdf:li>
    <rdf:li>Cixin He</rdf:li>
    <rdf:li>Chinyere E. Okpara</rdf:li>
    <rdf:li>Jodi McKenzie</rdf:li>
    <rdf:li>Toni K. Choueiri</rdf:li>
   </rdf:Seq>
  </dc:creator>
  <dc:description>
   <rdf:Alt>
    <rdf:li xml:lang='x-default'>Grünwald V, Powles T, Eto M, Kopyltsov E, Rha SY, Porta C, Motzer R, Hutson TE, Méndez-Vidal MJ, Hong S-H, Winquist E, Goh JC, Maroto P, Buchler T, Takagi T, Burgents JE, Perini R, He C, Okpara CE, McKenzie J and Choueiri TK (2023) Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms. Front. Oncol. 13:1343027</rdf:li>
   </rdf:Alt>
  </dc:description>
  <dc:rights>
   <rdf:Alt>
    <rdf:li xml:lang='x-default'>Copyright © 2024 Grünwald, Powles, Eto, Kopyltsov, Rha, Porta, Motzer, Hutson, Méndez-Vidal, Hong, Winquist, Goh, Maroto, Buchler, Takagi, Burgents, Perini, He, Okpara, McKenzie and Choueiri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</rdf:li>
   </rdf:Alt>
  </dc:rights>
  <dc:subject>
   <rdf:Bag>
    <rdf:li>renal cell carcinoma</rdf:li>
    <rdf:li>lenvatinib</rdf:li>
    <rdf:li>pembrolizumab</rdf:li>
    <rdf:li>sunitinib</rdf:li>
    <rdf:li>bone metastases</rdf:li>
    <rdf:li>liver metastases</rdf:li>
    <rdf:li>lung metastases</rdf:li>
    <rdf:li>sarcomatoid histology</rdf:li>
   </rdf:Bag>
  </dc:subject>
  <dc:title>
   <rdf:Alt>
    <rdf:li xml:lang='x-default'>Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms</rdf:li>
   </rdf:Alt>
  </dc:title>
 </rdf:Description>

 <rdf:Description rdf:about=''
  xmlns:pdf='http://ns.adobe.com/pdf/1.3/'>
  <pdf:Keywords>renal cell carcinoma, lenvatinib, pembrolizumab, sunitinib, bone metastases, liver metastases, lung metastases, sarcomatoid histology</pdf:Keywords>
 </rdf:Description>

 <rdf:Description rdf:about=''
  xmlns:xmpRights='http://ns.adobe.com/xap/1.0/rights/'>
  <xmpRights:Marked>True</xmpRights:Marked>
  <xmpRights:WebStatement>https://www.frontiersin.org/legal/copyright-statement</xmpRights:WebStatement>
 </rdf:Description>
</rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 222, 686, 509, 707
      Annotation: 
       Subtype: Link
       Rect: 222, 661, 528, 682
      Annotation: 
       Subtype: Link
       Rect: 222, 636, 528, 657
      Annotation: 
       Subtype: Link
       Rect: 222, 611, 425, 632
      Annotation: 
       Subtype: Link
       Rect: 222, 586, 527, 607
      Annotation: 
       Subtype: Link
       Rect: 222, 561, 399, 582
      Annotation: 
       Subtype: Link
       Rect: 236, 146, 530, 155
      Annotation: 
       Subtype: Link
       Rect: 236, 135, 530, 144
      Annotation: 
       Subtype: Link
       Rect: 236, 124, 294, 133
      Annotation: 
       Subtype: Link
       Rect: 251, 82, 339, 89
      Annotation: 
       Subtype: Link
       Rect: 49, 33, 119, 40
      Annotation: 
       Subtype: Link
       Rect: 500, 33, 545, 40
      Annotation: 
       Subtype: Link
       Rect: 49, 691, 125, 706
      Annotation: 
       Subtype: Link
       Rect: 60, 597, 159, 604
      Annotation: 
       Subtype: Link
       Rect: 49, 431, 152, 438
      Annotation: 
       Subtype: Link
       Rect: 61, 354, 180, 361
      Annotation: 
       Subtype: Link
       Rect: 49, 345, 74, 352
      Annotation: 
       Subtype: Link
       Rect: 458, 802, 492, 809
      Annotation: 
       Subtype: Link
       Rect: 474, 793, 522, 800
      Annotation: 
       Subtype: Link
       Rect: 454, 783, 541, 790
      Annotation: 
       Subtype: Link
       Rect: 49, 797, 221, 813
    Page: 
     Label: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 49, 744, 78, 753
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 242, 667, 273, 676
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 116, 579, 146, 588
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 455, 799, 545, 806
      Annotation: 
       Subtype: Link
       Rect: 49, 33, 119, 40
      Annotation: 
       Subtype: Link
       Rect: 500, 33, 545, 40
  Checksum: 29ec0992
   Type: CRC32
  Checksum: a5e2255f971bda3693f31978843844bb
   Type: MD5
  Checksum: 1f5cb3df1eea470287d2ff27ffefe53eaee62e23
   Type: SHA-1
  Checksum: 9a8d17ccc216774e4343b28fab628c907e055899234066b47dca9464f4181f2f
   Type: SHA-256